Review
Published on 12 Sep 2023
Literature review on hepatoprotective effects of diosgenin: possible mechanisms of action
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1226548
- 2,042 views
- 1 citation
Type at least 3 characters
1,085 articles
Articles
Perspective
Published on 08 Sep 2023
Postbiotics in the medical field under the perspective of the ISAPP definition: scientific, regulatory, and marketing considerations
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1239745
- 4,637 views
- 2 citations
Retraction
Published on 06 Sep 2023
Retraction: MiR-519b-3p inhibits the proliferation and invasion in colorectal cancer via modulating the uMtCK/Wnt signaling pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1285746
- 1,005 views
Original Research
Published on 06 Sep 2023
Glycyrrhizin arginine salt protects against cisplation-induced acute liver injury by repressing BECN1-mediated ferroptosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1219486
- 2,382 views
- 4 citations
Correction
Published on 05 Sep 2023
Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1281416
- 1,028 views
Clinical Trial
Published on 01 Sep 2023
Effects of acupuncture on gut microbiota and short-chain fatty acids in patients with functional constipation: a randomized placebo-controlled trial
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1223742
- 5,532 views
- 3 citations
Original Research
Published on 31 Aug 2023
N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1171353
- 1,723 views
- 1 citation
Review
Published on 31 Aug 2023
Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218432
- 4,699 views
- 2 citations
Review
Published on 30 Aug 2023
Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1237845
- 3,040 views
- 2 citations
Review
Published on 29 Aug 2023
Therapeutic potential of sulforaphane in liver diseases: a review
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1256029
- 7,260 views
- 5 citations
Original Research
Published on 28 Aug 2023
Inadequate gastric preparation and its associated factors for magnetically controlled capsule endoscopy
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184754
- 1,674 views
- 2 citations
Systematic Review
Published on 25 Aug 2023
Long-term proton pump inhibitors use and its association with premalignant gastric lesions: a systematic review and meta-analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1244400
- 4,347 views
- 1 citation
Study Protocol
Published on 24 Aug 2023
Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177539
- 2,577 views
Original Research
Published on 24 Aug 2023
YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1205062
- 1,801 views
- 2 citations
Review
Published on 23 Aug 2023
The role of gut microbiota and drug interactions in the development of colorectal cancer
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265136
- 2,724 views
- 3 citations
Original Research
Published on 17 Aug 2023
A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200254
- 5,840 views
- 6 citations